ArticleMolecular oncology2020

Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.

Shujuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.